Evidence map›Paper›PMID 32394344›Full record

ArticleInfection2020

COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients.

Georg Härter, Christoph D Spinner, Julia Roider, Markus Bickel, Ivanka Krznaric, Stephan Grunwald, Farhad Schabaz, Daniel Gillor, Nils Postel, Matthias C Mueller and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Infection, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 133 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
133citing papers in PubMed, 12 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

133 citing papers in PubMed, 12 syntheses or guidelines pooled it, 245 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. COVID-19 in People Living with HIV: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2021
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Observational
  14. Article
  15. COVID-19 Incidence and Factors Influencing Infection Risk Among People Living With HIV in Türkiye: Is Current Issue the Vaccine Hesitancy-Opposition?The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

73 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 1 country.

Georg HärterMedicover Ulm MVZ, Münsterplatz 6, 89073, Ulm, Germany. ghaerter@gmx.de.ORCID http://orcid.org/0000-0001-9946-6246
Christoph D SpinnerSchool of Medicine, Department of Medicine II, Technical University of Munich, University Hospital Klinikum rechts der Isar, Ismaninger Str. 22, 81675, München, Germany.
Julia RoiderSektion Klinische Infektiologie, Medizinische Klinik und Poliklinik IV, Klinikum der Universität, Ludwig-Maximilians-Universität München, Pettenkoferstrasse 8a, 80336, München, Germany.
Markus BickelInfektiologikum Frankfurt, Stresemannallee 3, D-60596, Frankfurt am Main, Germany.
Ivanka KrznaricZentrum für Infektiologie Berlin/Prenzelberg, Driesener Str. 11, 10439, Berlin, Germany.
Stephan GrunwaldZentrum für Infektiologie Berlin/Prenzelberg, Driesener Str. 11, 10439, Berlin, Germany.
Farhad SchabazMVZ Karlsplatz München, Karlsplatz 8, 80335, München, Germany.
Daniel GillorMVZ Innere Medizin Köln, Hohenstaufenring 59, 50674, Köln, Germany.
Nils PostelPrinzmed, Sendlinger-Tor-Platz 8, 80336, München, Germany.
Matthias C MuellerDepartment of Infection Medicine, Medical Care Center, MVZ Clotten, Berliner Allee 29, 79110, Freiburg, Germany.
Markus Müller, Stuttgart, Germany.
Katja Römer, Köln, Germany.
Knud ScheweICH Study Center Hamburg, Glockengießerwall 1, 20095, Hamburg, Germany.
Christian HoffmannICH Study Center Hamburg, Glockengießerwall 1, 20095, Hamburg, Germany.
German Center for Infection Research · DEGoethe University Frankfurt · DEInfektionsmedizinisches Centrum Hamburg · DEMedicover · DETH Köln - University of Applied Sciences · DETUM Klinikum · DEUniversity Hospital Schleswig-Holstein · DEUniversity of Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionData on people living with human immunodeficiency virus (PLWH) in the current SARS-CoV-2 pandemic are still scarce. This case series of 33 PLWH patients with COVID-19 reveals symptoms and outcome in this special population.

methodsRetrospective analysis of anonymized data including age, gender, HIV-associated parameters, symptoms, and outcome.

resultsThree out of 32 patients with documented outcomes died (9%). 91% of the patients recovered and 76% have been classified as mild cases. All patients were on antiretroviral treatment, of them 22 on tenofovir-containing regimen and 4 on the protease inhibitor darunavir.

conclusionsThis preliminary case series does not support excess morbidity and mortality among symptomatic COVID-19 PLWH and with viral suppression on ART. SARS-CoV-2 infections may occur during boosted darunavir-based and/or on tenofovir-containing ART.

Indexed as

AdultAntiretroviral Therapy, Highly ActiveBetacoronavirusCoinfectionCoronavirus InfectionsCOVID-19DarunavirFemaleHIVHIV InfectionsHumansMaleMiddle AgedPandemicsPneumonia, ViralRetrospective StudiesDarunavirTenofovirAIDSAntiretroviral therapyCOVID-19HIV infectionSARS-CoV-2

Identifiers

PMID32394344
PMCPMC7211976
OpenAlexW3022649665

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.